Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,147.50    8.50 (0.75%)
Bid:
1,148.00
Ask:
1,148.50
Spread: 0.50 (0.044%)
Market Cap: £9.74b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director Declaration

11 Feb 2021 07:00

RNS Number : 6810O
Smith & Nephew Plc
11 February 2021
 

11 February 2021

 

Smith & Nephew plc

 

DIRECTOR DECLARATION

 

In accordance with Listing Rule 9.6.14 R the Company announces that Roland Diggelmann, Chief Executive Officer, will be appointed as Non-Executive Director of Sonova Holding AG with effect from Sonova's AGM on 15 June 2021. Sonova shares are listed on the SIX Swiss Exchange (XSWX: SOON).

 

 

Susan Swabey

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477216

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGPUQAPUPGGQU
Date   Source Headline
27th Jul 20177:00 amRNSHalf-year Report
13th Jul 201711:42 amRNSNotice of Results
12th Jul 20174:44 pmRNSDirector/PDMR Shareholding
4th Jul 20178:04 amRNSDirectorate Change
3rd Jul 201710:56 amRNSTotal Voting Rights
8th Jun 20174:11 pmRNSTransaction in Own Shares
1st Jun 20171:59 pmRNSTotal Voting Rights
23rd May 20174:22 pmRNSTransaction in Own Shares
22nd May 20175:39 pmRNSTransaction in Own Shares
19th May 20175:18 pmRNSTransaction in Own Shares
18th May 20175:25 pmRNSTransaction in Own Shares
18th May 20172:29 pmRNSDirector/PDMR Shareholding
15th May 20171:54 pmRNSTransaction in Own Shares
12th May 20172:18 pmRNSDirector/PDMR Shareholding
11th May 201710:55 amRNSDirector/PDMR Shareholding
5th May 20177:00 amRNSTrading Statement
2nd May 201712:04 pmRNSTotal Voting Rights
26th Apr 20172:05 pmRNSDividend Declaration
11th Apr 20171:04 pmRNSNotice of Results
10th Apr 20174:12 pmRNSDirector/PDMR Shareholding
6th Apr 20174:50 pmRNSResult of AGM
3rd Apr 20173:07 pmRNSTotal Voting Rights
24th Mar 20173:03 pmRNSDirector/PDMR Shareholding
23rd Mar 20171:42 pmRNSAdditional Listing
10th Mar 20174:20 pmRNSDirector/PDMR Shareholding
8th Mar 20179:17 amRNSDirector/PDMR Shareholding
6th Mar 20171:49 pmRNSAnnual Financial Report - Replacement
6th Mar 20171:04 pmRNSAnnual Financial Report
1st Mar 20171:16 pmRNSTotal Voting Rights
21st Feb 20175:44 pmRNSTransaction in Own Shares
20th Feb 20175:46 pmRNSTransaction in Own Shares - Amendment
20th Feb 20175:28 pmRNSTotal Voting Rights
16th Feb 20175:44 pmRNSTransaction in Own Shares
15th Feb 20175:23 pmRNSDirector/PDMR Shareholding
14th Feb 20175:46 pmRNSTransaction in Own Shares
13th Feb 20174:08 pmRNSDirector/PDMR Shareholding
13th Feb 20179:23 amRNSTransaction in Own Shares
9th Feb 20177:05 amRNSDirectorate Change
9th Feb 20177:00 amRNSFinal Results
1st Feb 20176:28 pmRNSBlocklisting Interim Review
1st Feb 20175:28 pmRNSTotal Voting Rights
17th Jan 20175:05 pmRNSDirector/PDMR Shareholding
12th Jan 201712:14 pmRNSDirectorate Change
3rd Jan 20174:47 pmRNSTotal Voting Rights
21st Dec 20165:01 pmRNSNotice of Results
21st Dec 20161:48 pmRNSTransaction in Own Shares
19th Dec 20165:17 pmRNSTransaction in Own Shares
16th Dec 20165:13 pmRNSTransaction in Own Shares
15th Dec 20165:38 pmRNSTransaction in Own Shares
14th Dec 20165:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.